should the third dose be brought forward?

The progress of the third dose of the vaccine is one of the tracks that will be put on the table of the health council during the meeting on Friday, December 17. “The decrease in the levels of neutralizing antibodies begins at three months and becomes very significant at 5 months (…). We know that the booster dose has a booster effect by increasing the level of antibodies very quickly and greatly”, explains journalist Marina Carrère d’Encausse on the 19/20 set.

This reduction in time implies a completely different management of the existing vaccine stock, which at the beginning of December amounted to twenty million doses for Moderna, and five million doses for Pfizer. “Perhaps the most vulnerable people should be favored for this new deadline”, analyzes the journalist on the 19/20 set. Anti-covid drugs could also enter the pharmaceutical market, thanks to the validation of three molecules by the European Medicines Agency: Paxlovil, Xevudy and Kirenet.